Cellbox appoints Bernd Muehlenweg as new CBO and CFO
March 9, 2026Cellbox Solutions
Cellbox Solutions has appointed Bernd Muehlenweg as Chief Business Officer (CBO) and Chief Financial Officer (CFO). Bernd brings over 20 …
Antiverse receive investment from IIC and Development Bank of Wales
March 9, 2026Research and Development Antiverse, Wales, funding
As part of its $9.3m Series A funding round, Antiverse has received a joint equity investment by Innovation Investment Capital …
Five Facts about the menopause
March 6, 2026Medical Communications Five Facts, HRT, menopause, perimenopause
1 Menopause is when periods stop due to decreasing hormone levels. It generally begins between the ages of 45 and …
Zello Appoints Kevin Bailey as Group Chief Medical Officer
March 6, 2026Zello Group
Zello Group, a global workforce health and performance company, has appointed Dr Kevin Bailey as Group Chief Medical Officer (CMO). …
BioDuro establishes joint manufacturing venture with Cenra
March 6, 2026Manufacturing and Production BioDuro, Cenra API Solutions, manufacturing
BioDuro, a Contract Research, Development and Manufacturing Organisation (CRDMO), has established a joint venture with Cenra API Solutions, also known …
Symbiosis appoints Joanne Anderson as Chief Commercial Officer
March 6, 2026Symbiosis Pharmaceutical Services
Symbiosis Pharmaceutical Services (Symbiosis), a global contract development and manufacturing organisation (CDMO) specialising in the GMP sterile fill-finish manufacturing of …
Secarna Pharmaceuticals and Curie.Bio expand existing partnership
March 6, 2026Research and Development Curie.Bio, Secarna Pharmaceuticals, partnership
Secarna Pharmaceuticals has announced the expansion of the existing scientific and strategic collaboration agreement with Curie.Bio. The collaboration, first announced …
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer
March 6, 2026eXmoor Pharma
eXmoor Pharma has appointed Manuel Balbuena as Chief Commercial Officer (CCO). Manuel brings more than 15 years of commercial leadership …
ESTEVE CDMO commences $15.5m expansion of US facility
March 6, 2026Manufacturing and Production ESTEVE, US, expansion
ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, …
Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland
February 19, 2026Research and Development Siemens Healthineers
Siemens Healthineers has opened a new Centre of Excellence for Immunoassay Instrument Research & Development in Swords, Ireland. Over 10m …
Everdrone announces new board of directors to drive expansion
February 19, 2026Everdrone
Everdrone, a provider of autonomous drone systems for use in healthcare and emergency response, has appointed a new board of …
Regeneron announces presentations of new data on Eylea HD for retinal disease
February 18, 2026Research and Development Eylea HD, Opthalmology, Regeneron
Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data was presented as part of …
Indegene completes acquisition of Cake Health
February 18, 2026Cake Health, Indegene
Indegene, a life sciences solutions company, has announced its acquisition of Cake Health, a healthcare agency, as well as its …
Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals
February 17, 2026Manufacturing and Production Gedeon Richter UK, Neurology
Gedeon Richter UK has announced its acquisition of full marketing and distribution rights to Reagila (cariprazine), a schizophrenia treatment, from …
ENA Respiratory doses first patients with INNA-051 antiviral nasal spray
February 17, 2026Ear Nose & throat, Ena Respiratory
ENA Respiratory, a clinical-stage biopharmaceutical company specialising in the prevention of viral respiratory infections, has announced the first dosing of …
New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone
February 16, 2026Research and Development Cardiology, Carvolix
Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …
Qlaris Bio appoints Robert Warner to board of directors
February 16, 2026Qlaris Bio
Qlaris Bio has appointed Robert Warner to its board of directors. Warner brings significant experience in life sciences leadership to …
Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation
February 12, 2026Research and Development Cardiology, Rhythm AI, atrial fibrillation
Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …
iOrganBio appoints Karol Jarzabek as Chief Operating Officer
February 12, 2026Manufacturing and Production iOrganBio
iOrganBio has announced the appointment of Karol Jarzabek as Chief Operating Officer (COO). Jarzabek specialises in operational management and business …
Ensera Design expands UK leadership team with new senior appointments
February 11, 2026Business Services, Consultancy Ensera Design
Ensera Design, a healthcare product innovation consultancy, has announced the expansion of its UK leadership team with multiple new appointments. …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
